Crowdonomics
All companies

GOLD ENTERPRISE GROUP INC

Operating

Healthcare · Hudson, FL

Estimated pre-money ⓘ
$1.7M
As of Jul 2024 · from Reg A Offering (2024) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$131,659
Crowd $0 · Private $132K · 3 rounds since 2002
Latest share price
$11.0966
Private · Common Stock · Mar 2002 disclosed sale · in today's shares

Financials

FY2020–FY2024 (no data for FY2021, FY2022) · from SEC filings · hover any figure for its source
$0
−$46K
2020
2021no data
2022no data
$142K
−$19K
2023
$560K
−$89K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2023
FY2024
Income statement
Revenue
$0
$142,345
$559,545
Cost of goods sold
$45,558
$86,499
$331,787
Gross margin
—
39%
41%
Net income
-$45,558
-$19,345
-$89,467
Balance sheet
Cash
$16,512
$11,841
$9,737
Accounts receivable
$0
$34,012
$26,355
Total assets
$16,512
$72,225
$142,703
Long-term debt
$287,690
$223,245
$309,919
Total liabilities
$290,233
$385,639
$756,910
Other
Headcount
0
19
19

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$27.5M
est. pre-money
$1.7M
est. pre-money
Reg A+ · Equity · Nov 2021
Reg A+ · Equity · Jul 2024

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Jul 1, 2025
Class A Preferred Stock · 37.3%SERIES A · 0.01%PREFERRED SERIES B · 0%Common Stock · 62.7%
ClassOutstandingVotes / shareConvertsAs convertedVotesLast price
Class A Preferred Stockpreferred(as of Jan 31, 2025)2,000,0005,0005,000 × Common Stock37.3%27.2%—
SERIES Apreferred2,000,0005,000—0.01%27.2%—
PREFERRED SERIES Bpreferred(as of Apr 18, 2025)272,000none—0%0%—
Common Stock16,812,001,5131—62.7%45.7%$11.10Mar 2002
Total16,816,273,51326,814,273,513 as converted100%100%

Shares outstanding over timein today's share terms

16.8B8.4B0
Oct 2002Apr 2025
Class A Preferred StockClass B Preferred stockCommon StockPreferred StockSERIES APREFERRED SERIES B

Changes in named holdersshares in today's terms · % of all shares at the time

Principal holders% as the filing states it, Sep 20, 2024

  • IceLounge Media, Inc.2,000,000 PREFERRED SERIES A100.0%of PREFERRED SERIES A
  • LA Medical FL Inc c/o Mark Julian150,000 PREFERRED SERIES B47.0%of PREFERRED SERIES B
  • Devon Medical Products100,000 PREFERRED SERIES B31.0%of PREFERRED SERIES B
  • IceLounge Media, Inc.3,309,500,000 Common Stock19.7%of
  • Hamon Fytton3,309,500,000 Common Stock19.7%of
  • Medworx A Inc.3,309,500,000 Common Stock19.7%of
  • Soleeze Wave c/o Cathy Julian50,000 PREFERRED SERIES B15.0%of PREFERRED SERIES B
  • Hamon Fytton22,000 PREFERRED SERIES B7%of PREFERRED SERIES B

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. “As converted” counts each class in the shares it converts into. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $0 / $600KEst. pre-money $1.7M
Raised $0 / $2MEst. pre-money $27.5M

Team

3 people
Hamon Fytton
Chief Executive Officer, Secretary & Director
Cathy Julian
Chief Financial Officer & Director
James Kander
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 1-A-WOct 29, 20250001081188-25-000008
    EDGAR
  • Form 1-A/AJul 1, 20250001081188-25-000006
    EDGAR
  • Form 1-A/AApr 18, 20250001081188-25-000003
    EDGAR
  • Form 1-A/AFeb 10, 20250001081188-25-000002
    EDGAR
  • Form 1-A/ASep 20, 20240001081188-24-000006
    EDGAR
  • Form 1-AJul 23, 20240001081188-24-000005
    EDGAR
  • Form 1-A-WAug 1, 20220001081188-22-000005
    EDGAR
  • Form 1-A/ANov 5, 20210001081188-21-000019
    EDGAR
Source: SEC EDGARCIK 0001081188WYShare price $0.0001Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.